>> The recently presented draft bill for the Statutory Health Insurance Care Strengthening Act touches on a variety of topics. At the beginning of November, the BMC therefore organized a discussion forum for all interested parties, with BMG department head Dr. Ulrich Orlowski discussed intensively the design and opportunities of the innovation fund, the newly designed legal framework for selective contracts and the changes to outpatient and inpatient care structures.
The BMC has been calling for the establishment of an innovation fund for a long time: “The fund is a real opportunity to provide new impetus for the reform of supply structures,” said Prof. Dr. Volker Amelung, Chairman of the BMC. “However, so that funding applications are decided on the basis of factual rather than political criteria, it would make sense for the Innovation Committee to be more independent from its sponsor, the G-BA.” Dr. Rolf-Ulrich Schlenker, deputy chairman of the board of BARMER GEK and board member of the BMC, was concerned about the weighting of votes and composition of the innovation committee: “In order to underline the independence, a broader structure of the innovation committee would be recommended, for example by including scientists, patient representatives or even the Ministry of Science.” From the perspective...

... subscribers can find the detailed interview in archive